Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

Senate Adds Cancer Proposal to Defense Bill

December 7, 2012—The Senate Nov. 29 approved by voice vote an amendment to the fiscal year (FY) 2013 defense authorization bill (S. 3254) to require the director of the National Cancer Institute (NCI) to develop a scientific framework for the prevention, diagnosis, and treatment of recalcitrant cancers, such as pancreatic cancer, which have a five-year survival rate below 50 percent.

The amendment, offered by Sen. Sheldon Whitehouse (D-R.I.), was the text of his Recalcitrant Cancer Research Act (S. 3566), which was reported out of the Senate Health, Education, Labor and Pensions Committee in September [see Washington Highlights, Sept. 21]. The House of Representatives adopted similar language in September as H.R. 733

The Senate Dec. 4 passed the defense bill, 98-0, and incorporated it as an amendment into the House version of the reauthorization (H.R. 4310).

Contact: 

Dave Moore
Senior Director, Government Relations
Telephone: 202-828-0559
Email: dbmoore@aamc.org

.

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org